Home » Stocks » CVET

Covetrus, Inc. (CVET)

Stock Price: $29.21 USD -0.58 (-1.95%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 3.98B
Revenue (ttm) 4.34B
Net Income (ttm) -19.00M
Shares Out 118.00M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE 31.45
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $29.21
Previous Close $29.79
Change ($) -0.58
Change (%) -1.95%
Day's Open 30.11
Day's Range 28.77 - 30.20
Day's Volume 500,566
52-Week Range 7.51 - 40.77

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Our furry friends have taken care of us during this terrible pandemic. Now it's time to take care of them with these pet stocks to buy.

Other stocks mentioned: CENT, CHWY, CLX, HSKA, LMND
1 week ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the addition of Stacey M.M. Shirra as vice president of global talent management.

1 month ago - Business Wire

Covetrus (CVET) delivered earnings and revenue surprises of 25.00% and 5.88%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus reported financial results for the fourth quarter and full-year 2020, which ended December 31, 2020.

1 month ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #animalhealth--Covetrus appoints Link Welborn, DVM, DABVP as Covetrus' chief veterinary officer (CVO) in North America.

1 month ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release fourth quarter and full-year 2020 results the morning of Monday, March 1, 2021.

1 month ago - Business Wire

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET--Covetrus announced the appointment of its first-ever chief consumer officer.

1 month ago - Business Wire

LONDON & PORTLAND, Maine--(BUSINESS WIRE)--Covetrus received top recognition from the Learning Technologies Awards for its project with Dogs Trust, the largest dog welfare charity in the UK.

2 months ago - Business Wire

Covetrus, Inc. presents as a value proposition on a backdrop of incremental growth and successful acquisition integrations. Success in the high margin prescription management segment acts as a key growt...

3 months ago - Seeking Alpha

PORTLAND, Maine--(BUSINESS WIRE)-- #animalhealth--Animal-health technology and services company, Covetrus, to participate in the 39th Annual J.P. Morgan Healthcare Conference.

3 months ago - Business Wire

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

3 months ago - Zacks Investment Research

Covetrus (CVET) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 months ago - Zacks Investment Research

Finding cheap stocks isn't just about price -- it's about finding great companies that are trading at a discout to their actual worth. The post 5 Cheap Stocks With Great-Performing Companies appeared fi...

Other stocks mentioned: AB, ATCO, CODI, GTN
4 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus completes separation from former parent company ahead of schedule enabling the Company to deliver greater coordination of its businesses.

4 months ago - Business Wire

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Other stocks mentioned: FDS, HSIC, MRK, NSRGY, ZTS
4 months ago - InvestorPlace

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

4 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

4 months ago - Zacks Investment Research

Covetrus' (CVET) CEO Ben Wolin on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Covetrus (CVET) delivered earnings and revenue surprises of 43.75% and 8.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 52.94% year over year to $0.26, which beat the esti...

5 months ago - Benzinga

PORTLAND, Maine, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the third quarter of 202...

5 months ago - GlobeNewsWire

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
5 months ago - Zacks Investment Research

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results afte...

5 months ago - GlobeNewsWire

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

5 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

5 months ago - Zacks Investment Research

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
5 months ago - Zacks Investment Research

Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.

Other stocks mentioned: CHWY, FRPT, IDXX, PETS, SJM, ZTS
6 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus made a strategic investment in VSG, the leading provider of peer-to-peer learning experiences for veterinary practice leaders.

6 months ago - Business Wire

Covetrus, Inc. (NASDAQ : CVET; $22.98; Market Capitalization: $2.6 billion) is on a path of fast-tracked recovery as the company has managed to successfully reboot its operations in the U. S., where COV...

6 months ago - Forbes

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.

6 months ago - Business Wire

Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.

Other stocks mentioned: AMZN, MRK, NSRGY, ZTS
7 months ago - InvestorPlace

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus, a global leader in animal-health technology & services, announces appointment of Jamey Seely as general counsel effective Sept. 1, 2020.

7 months ago - Business Wire

PHOENIX--(BUSINESS WIRE)--Covetrus donated 6,000 bottles of hand sanitizer to help protect Phoenix communities and Arizona medical personnel from coronavirus.

7 months ago - Business Wire

CVET vs. SOGO: Which Stock Is the Better Value Option?

Other stocks mentioned: SOGO
8 months ago - Zacks Investment Research

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

8 months ago - Zacks Investment Research

Covetrus Inc. (CVET) CEO Ben Wolin on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q2 results.

8 months ago - Benzinga

Covetrus (CVET) delivered earnings and revenue surprises of 137.50% and 13.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

PORTLAND, Maine, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the second quarter of 2020, ...

8 months ago - GlobeNewsWire

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results...

8 months ago - GlobeNewsWire

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announces promotion of Ditte Marstrand Wulf to global chief human resources officer.

9 months ago - Business Wire

PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a quarterly...

9 months ago - GlobeNewsWire

With these three animal-health stocks, your portfolio will be stronger than ever.

Other stocks mentioned: ELAN, ZTS
9 months ago - The Motley Fool

The ProShares Pet Care ETF is the only ETF dedicated to pet stocks

Other stocks mentioned: CHWY, FRPT, GIS, IDXX, TRUP, ZTS
10 months ago - InvestorPlace

As of late, it has definitely been a great time to be an investor in Covetrus.

11 months ago - Zacks Investment Research

Covetrus Inc. (CVET) CEO Ben Wolin on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Covetrus (CVET) delivered earnings and revenue surprises of -5.56% and -0.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

Covetrus (CVET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

11 months ago - Zacks Investment Research

About CVET

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that in... [Read more...]

Industry
Health Information Services
Stock Exchange
NASDAQ
Ticker Symbol
CVET
Full Company Profile

Financial Performance

In 2020, Covetrus's revenue was $4.34 billion, an increase of 9.13% compared to the previous year's $3.98 billion. Losses were -$19.00 million, -98.06% less than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Covetrus stock is "Buy." The 12-month stock price forecast is 34.20, which is an increase of 17.08% from the latest price.

Price Target
$34.20
(17.08% upside)
Analyst Consensus: Buy